You wouldn’t think twice about asking your asthma patients to quit smoking, but have you ever asked them whether they have allergic rhinitis? Not such a strange question if you consider that 80% of patients with #asthma have #allergicrhinitis and...
Read more
OPRI is excited to share a milestone in asthma phenotype recognition! The ISAR #publication titled, ”Eosinophilic and Non eosinophilic Asthma, An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma...
Read more
The PCRS Respiratory Conference is the UK’s leading respiratory conference. Its aim is to inspire delegates to discover new ways of working with patients and colleagues, helping them to respond positively to the challenges of primary and...
Read more
A CRN supported Respiratory Disorders trial (TWICS), which investigated whether taking a low-dose theophylline tablets in addition to inhaled corticosteroids would reduce chronic obstructive pulmonary disease flare-ups was recently published by...
Read more
AT ATS 2018 SAN DIEGO – For people with COPD at high risk of exacerbation, the addition of low-dose theophylline to inhaled corticosteroids conferred no overall clinical benefit, results from a large trial funded by the United Kingdom...
Read more
A study in The Journal of Allergy and Clinical Immunology: In Practice found the majority of surveyed people with hay fever were not picking optimal over-the-counter medications to treat their symptoms.
Read more